4//SEC Filing
Crystal Adam 4
Accession 0000950170-25-014813
CIK 0001819133other
Filed
Feb 4, 7:00 PM ET
Accepted
Feb 5, 7:34 PM ET
Size
7.4 KB
Accession
0000950170-25-014813
Insider Transaction Report
Form 4
Crystal Adam
See Remarks
Transactions
- Award
Common Stock
2025-02-03+53,015→ 172,493 total - Award
Stock Option (Right to Buy)
2025-02-03+318,090→ 318,090 totalExercise: $2.91Exp: 2035-02-03→ Common Stock (318,090 underlying)
Footnotes (2)
- [F1]These shares are represented by restricted stock units (the "RSUs"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. The RSUs will vest over a three year period at a rate of 33% on February 2, 2026, 33% on February 1, 2027 and 34% on February 14, 2028, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date.
- [F2]This option shall vest and become exercisable over a four-year period, at a rate of 25% on January 1, 2026, with the remaining option shares vesting in 36 equal monthly installments thereafter.
Documents
Issuer
Tango Therapeutics, Inc.
CIK 0001819133
Entity typeother
Related Parties
1- filerCIK 0001825445
Filing Metadata
- Form type
- 4
- Filed
- Feb 4, 7:00 PM ET
- Accepted
- Feb 5, 7:34 PM ET
- Size
- 7.4 KB